| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_843659aad9c4fcabeaa8bd2c0728a181 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-19 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N37-46 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate |
2020-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11e3ca902f57e7d5066747eaac80320e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e18ba587bafdadc9f0ebcae6b8a2e8d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ef71749098f9abb241a683b977cbd92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f22753ef8cbfe9b7f29430258d9eb0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4272a448da2c64615b0e8c5398f5758
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_857664b5df5ae01e535f6e0c7b027204 |
| publicationDate |
2021-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210149377-A |
| titleOfInvention |
Antibacterial Protein CEL200 Having Lytic Activity to Clostridioides difficile |
| abstract |
The present invention is Clostridioides difficile difficile ) relates to the antibacterial protein CEL200 having specific antibacterial activity against bacteria, and more specifically, the ability to specifically lyse Clostridioides difficile, which can cause disease by infecting animals including humans Antibacterial protein CEL200 specific to Clostridioides difficile characterized in that it contains the amino acid sequence represented by SEQ ID NO: 1 and a method for producing the same, and the Clostridioides difficile specific antibacterial protein CEL200 It relates to a pharmaceutical composition for treating infections or diseases caused by Clostridioides difficile, including as an active ingredient. |
| priorityDate |
2020-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |